Paul Mampilly recently released a teaser for his Banyan Hill’s newsletter Profits Unlimited. He noted that “The Company Leading the Precision Medicine Revolution is the next bigh thing”. “It is foremost diligence in molecular analytical DNA sequencing to evaluate if an individual will develop an illness and to decide which drug treatment an individual will best retort to. This company targets different forms of cancerous diseases from lung, ovarian, prostrate to breast cancer and a whole lot of other chronic illnesses.
This is considered as the greatest breakthrough in history of medicine. It is believed that by looking at an individual’s DNA and being able to prepare a medicine to fit that individual’s specific genetic make. Diseases can also be prevented from developing since it can be customized outfit to fit a person. And if this could be possible then chronic diseases such as diabetes, Parkinson and Alzheimer’s could be cleared by looking at an individual’s DNA. This could be more important than every vaccination, medical device and all drugs. This will be a Radical Approach to undertaking Infection that will totally alter the game and kindle A Health Revolt.
It is thanks to all these changes that precision medicine is set to bring that Paul Mampilly advises his subscribers to buy stakes in companies such as Myriad genetics because they’ll cash in big once the plan is put into action. Already Myriad is doing well in the stock market and as such investors are asked to chip in so they can reap mega profits. Follow Paul on Facebook.
A little insight on Paul Mampilly
Paul Mampilly is a high-ranking Publishing supervisor of true momentum, Extreme Fortunes and profit unlimited at the Banyan Hill Publication. Because of his knowledge, skills and experience as a previous Wall Street insider he educates many of his clients into bonds that are informed to be higher in the near future.
Mampilly was born in India and he went to United States of America at a tender age where he grew titles in Wall Street. Paul started his career as a vice portfolio supervisor at the Bankers trust in 1991. He rapidly rose to noticeable positions running multimillion dollar financial records for Deutsche Bank and ING. Paul graduated from University of Fordham in 1996 with Master in Business Administration.
In 2013 he opened capuchin consulting that is greatly assisting people make a lot of profit over their investments. After gaining all the experience, he decided not to be part of wall street anymore.
The reason was that the wall street did not do enough to help people in spending their money. He had a thought of starting a newsletter which now enables him to be in a position to aid people from all standards of life.
Contrary to the Wall Street which only focused on wealthy people, Mampilly is pleased with his research because what he engages now is within the rich of most individuals. With latest trends relating to Cryptocurrency, altcoins and Bitcoins, Mampilly is busy cautioning those who look to make a fast dollar about the predictable cryptocurrency bust. Read more: http://www.talkmarkets.com/contributor/Paul-Mampilly/